United Kingdom· GB-APID-45706811000001108
Itovebi 9mg tablets
A inavolisib product containing inavolisib, registered in United Kingdom by Roche Products Ltd. The same ATC class is registered in 10 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Inavolisib is registered in 10 of 19 countries.
Countries holding a registration under ATC L01EM06 (inavolisib), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 7 of them publish a price we can compare per daily dose
Inavolisib · ATC L01EM06
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Icelandprice
- Ireland
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Inavolisib
- Manufacturer
- Roche Products Ltd
- Country
- United Kingdom (GB)
- ATC code
- L01EM06
- ATC class
- Inavolisib
- Defined daily dose
- 9 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin07613326093279
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Inavolisib in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CanadaITOVEBIHOFFMANN-LA ROCHE LIMITED
- BelgiumItovebi 3 mgRoche Registration
- SwitzerlandItovebi 3 mg, FilmtablettenRoche Pharma (Schweiz) AG
- CzechiaITOVEBIRoche Registration GmbH, Grenzach-Wyhlen
- SpainITOVEBI 3 MG COMPRIMIDOS RECUBIERTOS CON PELICULARoche Registration Gmbh
- FinlandItovebiRoche Registration GmbH
- FranceITOVEBI 3 mg, comprimé pelliculéROCHE REGISTRATION (ALLEMAGNE)
- United StatesItovebiGenentech, Inc.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Itovebi
- Liechtenstein · Itovebi
- Norway · Itovebi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c2dc1227-b9c1-4608-b73b-ae130756b04d GET /v1/drugs/c2dc1227-b9c1-4608-b73b-ae130756b04d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "45706811000001108",
"desc": "Itovebi 9mg tablets (Roche Products Ltd)",
"form": "Oral tablet",
"vpid": "45708311000001100",
"source": "dmd",
"vtm_id": "45707211000001109",
"strength": "9 mg",
"substance": "Inavolisib",
"ingredient": "Inavolisib",
"supplier_code": "2085201000001100"
}See everything about inavolisib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.